You are here: Home > Institute of Excellence (CPD) > Calendar > CPD Events > PHARMA – June 2019

PHARMA - June 2019


Learning Objectives

  • Gain an understanding on the functional vision loss experienced by patients with ring scotomas due to AMD and how to manage such patients
  • Become more familiar with the various peripheral retinal changes that occur in AMD and how these can be detected
  • Become more familiar with the ocular conditions optometrists usually experience and challenges faced in domiciliary eye care
  • Become more familiar with the factors associated with anti-VEGF therapy in the treatment of neovascular AMD
  • Gain an understanding of the clinical classification of AMD
  • Become more familiar with the evidence-based modifiable lifestyle risk factors associated with AMD
  • Become more familiar with the LEAD trial and the potential role of nanosecond laser treatment for AMD
  • Become more familiar with the use of OCT in the investigation of various systemic neurologic disease
  • Gain an understanding of how to differentiate macular dystrophies from AMD
  • Gain an understanding of the support and services provided by low vision providers and when it may be appropriate to refer patients to such providers

Max CPD hours awarded: 4.5

Session Information

Name
PHARMA - June 2018
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
3
Duration of CPD Session/Module inclusive of Assessment Component
4.5